Correlation Between Nordea Invest and Novo Nordisk

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nordea Invest and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nordea Invest and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nordea Invest Basis and Novo Nordisk AS, you can compare the effects of market volatilities on Nordea Invest and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nordea Invest with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nordea Invest and Novo Nordisk.

Diversification Opportunities for Nordea Invest and Novo Nordisk

-0.19
  Correlation Coefficient

Good diversification

The 3 months correlation between Nordea and Novo is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Nordea Invest Basis and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Nordea Invest is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nordea Invest Basis are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Nordea Invest i.e., Nordea Invest and Novo Nordisk go up and down completely randomly.

Pair Corralation between Nordea Invest and Novo Nordisk

Assuming the 90 days trading horizon Nordea Invest is expected to generate 2.41 times less return on investment than Novo Nordisk. But when comparing it to its historical volatility, Nordea Invest Basis is 3.63 times less risky than Novo Nordisk. It trades about 0.06 of its potential returns per unit of risk. Novo Nordisk AS is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  46,814  in Novo Nordisk AS on September 26, 2024 and sell it today you would earn a total of  15,446  from holding Novo Nordisk AS or generate 32.99% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.59%
ValuesDaily Returns

Nordea Invest Basis  vs.  Novo Nordisk AS

 Performance 
       Timeline  
Nordea Invest Basis 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Nordea Invest Basis are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Nordea Invest is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Novo Nordisk AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Nordea Invest and Novo Nordisk Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nordea Invest and Novo Nordisk

The main advantage of trading using opposite Nordea Invest and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nordea Invest position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.
The idea behind Nordea Invest Basis and Novo Nordisk AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments